Status:
COMPLETED
Genomics of Primary Sclerosing Cholangitis (PSC)
Lead Sponsor:
Mayo Clinic
Conditions:
Primary Sclerosing Cholangitis (PSC)
Eligibility:
All Genders
5-90 years
Brief Summary
Primary Sclerosing Cholangitis (PSC) is a progressive liver disorder of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with envir...
Eligibility Criteria
Inclusion
- Men, Women, and Children between the ages of 5-90 with a history of PSC.
- PSC patients who have had a liver transplant are eligible.
- Family members (1st degree relatives) of enrolled PSC patients are eligible.
Exclusion
- Individuals with no history of PSC or those unable to provide consent.
Key Trial Info
Start Date :
March 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT01161992
Start Date
March 1 2002
End Date
July 31 2025
Last Update
August 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55901